Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Cook

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Thrombosis Research|June 15, 1996
Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonistJ S Bostwick, C J Kasiewski, V Chu, et al.
The Journal of Surgical Research|August 1, 1991
Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availabilityS J Fishman, L J Wylonis, J D Glickman, et al.
Circulation|June 15, 1995
An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkeyJ J Cook, G R Sitko, B Bednar, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383J J Lynch, J J Cook, G R Sitko, et al.
Journal of Medicinal Chemistry|August 18, 1995
Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonistM E Duggan, A M Naylor-Olsen, J J Perkins, et al.
Journal of Medicinal Chemistry|January 19, 1996
Investigation of (Oxodioxolenyl)methyl carbamates as nonchiral bioreversible prodrug moieties for chiral aminesJ Alexander, D S Bindra, J D Glass, et al.
Journal of Medicinal Chemistry|November 8, 1996
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ H Hutchinson, J J Cook, K M Brashear, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitorsG D Hartman, M E Duggan, W F Hoffman, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Thrombosis Research|June 15, 1996
Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonistJ S Bostwick, C J Kasiewski, V Chu, et al.
The Journal of Surgical Research|August 1, 1991
Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availabilityS J Fishman, L J Wylonis, J D Glickman, et al.
Circulation|June 15, 1995
An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkeyJ J Cook, G R Sitko, B Bednar, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383J J Lynch, J J Cook, G R Sitko, et al.
Journal of Medicinal Chemistry|August 18, 1995
Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonistM E Duggan, A M Naylor-Olsen, J J Perkins, et al.
Journal of Medicinal Chemistry|January 19, 1996
Investigation of (Oxodioxolenyl)methyl carbamates as nonchiral bioreversible prodrug moieties for chiral aminesJ Alexander, D S Bindra, J D Glass, et al.
Journal of Medicinal Chemistry|November 8, 1996
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ H Hutchinson, J J Cook, K M Brashear, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitorsG D Hartman, M E Duggan, W F Hoffman, et al.
Pageof 5